Weight Loss & GLP-1

Two incretin-receptor compounds. Tirzepatide is built on the GIP sequence with GLP-1 activity added and a fatty diacid that binds albumin. Retatrutide agonises a third receptor, glucagon, from one molecule, with reported potency strongly favouring GIPR. Comparing them isolates what glucagon-receptor activity adds. Category names here describe research focus, not outcomes.

Supplied for in-vitro laboratory research only. Not for human or veterinary use.